Biologics
-
Biologics
MIMEDX’s EPIFIX Gains Japanese Regulatory Approval
Availability of EPIFIX allografts is expected early 2022.Globe Newswire 06.08.21
-
Biologics
FDA OKs Elute's Antibiotic Eluting Bone Void Filler Trial
Will evaluate EP Granules with Tobramycin in difficult-to-treat bone infections.Sam Brusco, Associate Editor 06.08.21
-
Biologics
Aziyo Biologics Recalls One Lot of FiberCel Fiber Viable Bone Matrix
Some patients that tested positive for tuberculosis after treatment.Michael Barbella, Managing Editor 06.07.21
-
Biologics
Paragon 28 Adds Three Families of DBM to its Biologics Portfolio
Company now offers BEAST Injectable, BEAST PLUS, and BEAST Osteobiologic Sponge for bone grafting applications in the foot and ankle.Michael Barbella, Managing Editor 05.21.21
-
Biologics
Clinical Data Show High Fusion Rates With ProteiOS Growth Factor
Biologica Technologies' allograft-derived growth factor leads to fusion rates that are higher or comparable to those in other published studies.Michael Barbella, Managing Editor 05.18.21
-
Biologics
Biogennix Rolls Out Agilon Strip Bone Graft
Agilon Strip maximizes direct contact with bone when implanted.Sam Brusco, Associate Editor 04.14.21
-
Biologics | Large Joint
Bioventus Begins Trial of MOTYS (PTP-001) to Treat Knee OA
MOTYS is a placental tissue particulate comprised of amnion, chorion, and umbilical cord tissue.Sam Brusco, Associate Editor 03.15.21
-
Biologics
Medtech Matters: FDA’s Ambiguity on Hyaluronic Acid
MPO's Sean Fenske speaks with Mike Daley of OrthogenRx about the role HA plays in alleviating knee pain and the challenges with the FDA over it.Sean Fenske, Editor-in-Chief 03.02.21
-
Biologics
Paragon 28 Launches MgNum Bone Void Filler
Expands its biologics portfolio.Charles Sternberg, Assistant Editor 02.22.21
-
Biologics
Washington University Professor Honored for Functional Cartilage Engineering Research
Scholar's research is soon expected to begin a Phase I clinical trial.Michael Barbella, Managing Editor 02.22.21
-
Biologics
Ranfac, Endocellutions Form Cervos Medical
Cervos Medical represents a joint venture to bring next generation surgical and orthobiologic devices to the market.Sean Fenske, Editor-in-Chief 02.19.21
-
Biologics
The FDA’s Flip-Flop on Hyaluronic Acid
Offering an introduction to this treatment modality for osteoarthritis, this article also looks at recent changes at FDA.Online Exclusives Mike Daley, CEO, OrthogenRx 02.10.21
-
Biologics
Helping Nature Take Its Course: A Biologics Breakdown
Examining the technologies designed to help the body heal itself following orthopedic and spinal surgery.Sam Brusco, Associate Editor 02.08.21
-
Biologics
An FDA Regulatory Perspective on Bone Grafts
There are various bone grafts with different composition, source, mechanical strength, and functional biological mechanisms.Mehdi Kazemzadeh-Narbat, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 02.08.21
-
Biologics | Trauma/Sports
Geistlich Pharma's Chondro-Gide Articular Cartilage Cover Earns Breakthrough Status
The collagen membrane is used in a single-step cartilage repair technique.Sam Brusco, Associate Editor 02.03.21
-
Biologics
FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
Company's biomaterial uses a plant-based cellulose scaffolding to create a framework that supports the regeneration of healthy tissues.Spiderwort Inc. 01.20.21
-
Biologics
Surgalign Launches New Device for Bone Formation
ViBone Moldable is the newest orthobiologics solution of Surgalign’s bone graft portfolio to support spinal fusion.GlobeNewswire 01.13.21
-
Biologics
Locate Bio’s CognitOss for Chronic Osteomyelitis Earns Breakthrough Status
Combines resorbable bone graft with bone healing properties and proprietary dual-phasic release of antibiotics.Business Wire 01.11.21
-
Biologics
Evonik Launches Next-Generation PEEK Biomaterial for Medtech Applications
VESTAKEEP iC4800's mechanical properties are similar to those of human bone.Evonik Industries AG 12.03.20
-
Biologics | Spine/Neurology
Surgalign, Aziyo Biologics Expand Distribution Deal
Boosts availability of ViBone Moldable, a next-gen moldable cellular bone matrix product.GlobeNewswire 11.17.20
